<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02032953</url>
  </required_header>
  <id_info>
    <org_study_id>12-459-GEN</org_study_id>
    <nct_id>NCT02032953</nct_id>
  </id_info>
  <brief_title>Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia</brief_title>
  <official_title>Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out whether adding insulin after current colorectal
      cancer surgery promotes making and keeping proteins in the body, and to find out whether or
      not this effect can be further increased by increasing the amount of protein given.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Net protein balance</measure>
    <time_frame>6 hours after surgery</time_frame>
    <description>The difference in total body protein after randomization to one of the three treatment arms.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Insulin, Travasol (35%) postop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Insulin (hyperinsulinemic-normoglycemic clamp) with Travasol (amino acid supplementation) given from start of surgery to 6 hours after, at an amount of 35% of patient's energy expenditure as measured before surgery, .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin, Travasol (20%) postop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Insulin (hyperinsulinemic-normoglycemic clamp) with Travasol (amino acid infusion), given from start of surgery to 6 hours after, at an amount of 20% of patient's energy expenditure as measured before surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin, no protein after surgery</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Insulin (hyperinsulinemic-normoglycemic clamp, an insulin infusion between 2 and 5 microunits/kg with glucose at a variable rated titrated to maintain normoglycemia, blood glucose 4-6 mmol/L) with no protein supplementation from start of surgery to 6 hours after.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Travasol (amino acid injection)</intervention_name>
    <description>an amino acid supplementation infused intravenously containing essential and non-essential amino acids</description>
    <arm_group_label>Insulin, Travasol (35%) postop</arm_group_label>
    <arm_group_label>Insulin, Travasol (20%) postop</arm_group_label>
    <other_name>Travasol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin</intervention_name>
    <description>After the insertion of an arterial catheter and obtaining a baseline arterial blood glucose value, 2 units of insluin will be administered iv followed by an infusion of 2 microunits/kg*min. Ten minuts after starting the insulin, and when the the blood glucose is&lt;6 mmol/L, dextrose 20% supplemented with phosphate (30mmol/L) will be infused. Blood glucose levels measured every 15 minutes and the dextrose infusion rate adjusted to maintain arterial glycemia between 4 and 6 mmol/L until end of study.</description>
    <arm_group_label>Insulin, Travasol (35%) postop</arm_group_label>
    <arm_group_label>Insulin, Travasol (20%) postop</arm_group_label>
    <arm_group_label>Insulin, no protein after surgery</arm_group_label>
    <other_name>HNC</other_name>
    <other_name>Hyperinsulinemic-normoglycemic clamp</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists class&lt;3

          -  age&gt;18 years

          -  colorectal surgery for non-metastatic colorectal adenocarcinoma including right and
             left hemicolectomy, transverse, subtotal and total colectomy sigmoid and low anterior
             resection

          -  ability to give informed consent

        Exclusion Criteria:

          -  BMI&gt;30 Kg/meter squared

          -  confirmed diagnosis of diabetes mellitus or a HbA1c&gt;6.0%

          -  significant cardiorespiratory, hepatic, renal and neurological disease

          -  musculoskeletal or neuromuscular disease

          -  ingestion of drugs known to affect protein, glucose and lipid metabolism (e.g.
             steroids)

          -  severe anemia (hemoglobin&lt;10 g/dL

          -  pregnancy

          -  history of severe sciatica, back surgery or other conditions which contraindicate the
             use of epidural catheters
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Schricker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McGill University Health Centre (MUHC) - Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H8A1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Schricker T, Meterissian S, Wykes L, Eberhart L, Lattermann R, Carli F. Postoperative protein sparing with epidural analgesia and hypocaloric dextrose. Ann Surg. 2004 Nov;240(5):916-21.</citation>
    <PMID>15492576</PMID>
  </reference>
  <results_reference>
    <citation>Schricker T, Wykes L, Carli F. Epidural blockade improves substrate utilization after surgery. Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E646-53.</citation>
    <PMID>10950834</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2014</study_first_submitted>
  <study_first_submitted_qc>January 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2014</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Center</investigator_affiliation>
    <investigator_full_name>Thomas Schricker</investigator_full_name>
    <investigator_title>Chief of Anesthesia</investigator_title>
  </responsible_party>
  <keyword>colorectal cancer</keyword>
  <keyword>protein recovery</keyword>
  <keyword>perioperative nutrition</keyword>
  <keyword>hyperinsulinemia</keyword>
  <keyword>normoglycemia</keyword>
  <keyword>hyperinsulinemic-normoglycemic clamp</keyword>
  <keyword>anabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Anabolic Agents</mesh_term>
    <mesh_term>Amino-acid, glucose, and electrolyte solution</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

